miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
about
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs as Important Players in Host-hepatitis B Virus InteractionsHepatitis B Virus Infection, MicroRNAs and Liver DiseaseHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesHost cellular microRNA involvement in the control of hepatitis B virus gene expression and replicationHepatitis B virus molecular biology and pathogenesisModulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1αMiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin.MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.MicroRNAs associated with HBV infection and HBV-related HCC.Complex interactions between microRNAs and hepatitis B/C viruses.miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2)MiRNA expression profile for the human gastric antrum region using ultra-deep sequencingThe "Macro" World of microRNAs in Hepatocellular Carcinoma.Nasal mucosal microRNA expression in children with respiratory syncytial virus infection.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis.Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells.New insights on the role of epigenetic alterations in hepatocellular carcinoma.MicroRNA profile comparison of the corneal endothelia of young and old mice: implications for senescence of the corneal endotheliummicroRNAs in liver disease: from diagnostics to therapeutics.Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster.A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death.Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.Role of microRNAs in inflammation-associated liver cancerMicroRNAs in Liver Disease: Bench to Bedside.The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review.MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.Regulation of NF-κB by deubiquitinases.Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment.MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacyAn emerging role for microRNAs in NF1 tumorigenesis.The role of microRNAs in tumors.The deubiquitinase A20 in immunopathology of autoimmune diseases.Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis.
P2860
Q26773183-0214205B-B6E6-4C2F-9997-F98E2398F915Q26781737-07CE7374-383E-4CF8-9B6C-1B640AC1C475Q26801511-660F13B0-DEBA-4873-BC52-FE817CF6877BQ27024630-2BC024E1-1345-4703-88BC-434B427F3721Q27027473-2BDAA3F8-3B3D-4240-934B-3E3BA8A073F7Q28818406-345FDB22-14A6-446A-BDBE-CED59E5C90FDQ33698542-4F1FD875-0561-4BBD-B964-75F410B2956EQ33725787-2C5B7B10-0646-4487-BD94-EB1B24CEB897Q34256676-2C4F16C6-3E85-4B34-BF4C-5715E6B09545Q34284404-F8F1C0CE-5867-406B-B039-E3073FA08BECQ34302987-F2A24A09-11A0-4662-A466-21BDC009DC9FQ34925168-64DE16D5-9274-4F12-A9F9-692249E88AACQ35125085-0F278487-AE14-441F-A36B-CAB2135F6ED2Q35215896-68179710-DC4B-48F6-8561-ABDEE6CA7A82Q35293673-96DB133E-31B2-408A-B12F-3F3A1707EC2BQ35343911-C3F6BADB-FC5C-47DB-9AD6-EA1E05B274C2Q35636725-E6FD38C6-FA3E-4A85-B5D6-B781D29886A9Q35674157-F70D52C2-5DCF-4969-B56D-E5A88D622165Q36316724-360DC52B-717F-43B1-92DC-F70AABF6DF1FQ36381117-853761F7-5848-4F8D-8708-98D326FD8CEEQ36545975-7E69816B-7768-4464-BD1D-0FF3C4646E5CQ36624105-AC791ABF-B000-46B1-BBA7-070B2FD18A36Q37031728-7E16BE6F-9B9A-4878-A7D7-A2CF5E91724DQ37091622-B60F6ADE-AF58-4F87-9590-A2342D06D4DEQ37246198-163FF530-3F3F-4465-910B-70C31D254C60Q37336779-D47CFFAA-673F-433F-AAF2-1E74D1292385Q37482764-537EA5CC-51DC-4E1A-B29F-9787456334CDQ37547012-C666F23A-3C31-41F0-B5A0-64E67F2B2B42Q37596666-06EEEAC7-27BC-4F34-96B9-2BA082C00C0DQ37613598-FDD6E43E-997F-44CF-AD7B-1A2D81E3AC73Q37642381-20199947-EFC5-4363-9787-37551DBE3791Q37691434-8445DB53-61BF-40F4-95D2-20C0BA756E1BQ37995682-480BF01B-EDBD-4800-87E2-0B774CDD3629Q37998154-0532AD83-9F46-4EF4-A0FA-853C4B5BFDDFQ38018170-A2B9C5B5-7B2D-4769-BD2B-E9874F9053EAQ38060281-A8DBCED8-CC95-44EA-938B-AA1FAC32BD75Q38123756-33235951-F05A-4092-BE0A-EBBB4503A606Q38199722-E4B72A44-320E-4CD4-A871-120AC7D58079Q38223512-B44F83C4-3435-4B60-8433-74F37C8239A9Q38257098-A317DB22-355B-4B11-B7D4-7B7C5C38083C
P2860
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@en
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@nl
type
label
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@en
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@nl
prefLabel
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@en
miR-29c targets TNFAIP3, inhib ...... ated hepatocellular carcinoma.
@nl
P2093
P1476
miR-29c targets TNFAIP3, inhib ...... lated hepatocellular carcinoma
@en
P2093
Chun-Guang Fan
Chun-Mei Wang
Fei-Fei Xu
Ji-Hui Jia
Wen-Sheng Sun
P304
P356
10.1016/J.BBRC.2011.06.191
P407
P50
P577
2011-07-06T00:00:00Z